Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures following single and multiple-dosing.
Epistemonikos ID: a855ae220579dace89de959e7630377116203f9f
First added on: May 08, 2024